Cohere Buys Aleph Alpha: Germany's AI Champion Goes Canadian

Cohere acquires Germany's Aleph Alpha, shrinking Europe's AI sovereignty options. Plus GPT-5.5 regression complaints mount, and new tools for builders.

Cohere Buys Aleph Alpha: Germany's AI Champion Goes Canadian
Photo by Cytonn Photography on Unsplash

Editorial digest April 24, 2026
Last updated : 11:01

The story of the day

Reuters, citing Handelsblatt, reports Cohere is acquiring Aleph Alpha. The Toronto-based enterprise LLM company is swallowing Germany's flagship AI lab — the one that for three years was pitched, in policy papers and funding rounds, as Europe's counterweight to OpenAI.

This collapses one of the few remaining European frontier-adjacent labs into foreign ownership. For EU policymakers who spent two years repeating "strategic autonomy," the message lands hard: the continent's most visible independent lab couldn't stay independent. Cohere, for its part, inherits Aleph Alpha's German ministry and industrial customer relationships — a compliance-heavy beachhead that would have taken years to build from scratch, and the fastest route yet into Europe's most regulated procurement pipelines.

Expect accelerated sovereign-cloud partnerships. Expect uncomfortable questions in Berlin about why the government's preferred lab is now owned in Canada. For builders evaluating European AI vendors with on-soil requirements, the shortlist just got shorter — and the negotiating leverage just moved across the Atlantic.

New tools & launches

Fit.ly — AI outfit generator, browser-based consumer app. Niche, early-stage (Render-hosted). [Hacker News]

Thin day for launches. The signal is consolidation, not shipping.

Models & research

Healthcare AI's outcomes gap — A Nature Medicine paper by Jenna Wiens (Michigan) and Anna Goldenberg (Toronto), flagged by MIT Technology Review, argues that most deployed medical AI — notetaking copilots, records triage, imaging interpretation — is validated on accuracy metrics, not on actual patient outcomes. The authors call for prospective clinical trials rather than retrospective benchmarks. A useful reality check for a healthcare AI market running largely on validation theater. [MIT Technology Review]

GPT-5.5 Pro benchmark regression — Users flag that 5.5 Pro posts a lower HLE (with tools) score than 5.4 Pro. If confirmed across runs, it's an unusual admission of trade-offs at the frontier — faster inference, weaker reasoning depth. Proprietary; no technical report from OpenAI explaining the delta. [Reddit r/OpenAI]

Community pulse

GPT-5.5 under-thinks. Three separate r/OpenAI threads in 24 hours converge on the same complaint: 5.5 Pro returns in ~2 minutes where 5.4 Pro took ~40, skims references, and ignores custom instructions. Consensus among power users is faster-but-worse. Dissent is minimal. No official response from OpenAI yet. [Reddit r/OpenAI]

Claude + Codex cross-review. A builder on the 20x Claude plan reports running Opus 4.7 and Codex CLI in tmux as a PR-review loop: Claude opens, Codex reviews, Claude edits. Claims it catches bugs single-model self-review misses. Small trend worth watching — multi-model orchestration quietly moving from novelty to production workflow. [Reddit r/OpenAI]

Stat of the day

~2 minutes — the time GPT-5.5 Pro took to process 72 academic references in a user-reported benchmark, versus the ~40-minute thinking traces the same user got from 5.4 Pro on comparable tasks. Roughly 1.7 seconds per reference. Fast. Whether the output is worth reading is the open question OpenAI hasn't answered.

Get the full analysis — subscribe to Gradient Pro.